{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T13:33:33Z","timestamp":1783690413960,"version":"3.55.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T00:00:00Z","timestamp":1663545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.82101726"],"award-info":[{"award-number":["No.82101726"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["No.2020CFA021"],"award-info":[{"award-number":["No.2020CFA021"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Principal Investigator Grant of Biomedical Research Institute of Hubei University of Medicine","award":["No.HBMUPI201802"],"award-info":[{"award-number":["No.HBMUPI201802"]}]},{"name":"Scientific Technological Project of Shiyan City of Hubei Province","award":["No.2021K64"],"award-info":[{"award-number":["No.2021K64"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The gonadotropin-releasing hormone agonist (GnRH-a) has been used in in vitro fertilization\/intracytoplasmic sperm injection (IVF\/ICSI) cycles for a long time. This paper evaluates the efficacy and safety of two commonly used protocols (follicular-phase depot GnRH-a protocol and daily mid-luteal long GnRH-a protocol) in normal responders undergoing IVF\/ICSI using propensity score matching (PSM) analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 6,816 infertile women treated within the period from January 2016 to September 2020 were stratified into cohorts. A total of 2,851 patients received the long-acting group (depot GnRH-a protocol), and 1,193 used the short-acting group (long GnRH-a protocol) after the data-selection process. PSM was utilized for sampling by up to 1:1 nearest neighbour matching to adjust the numerical difference and balance the confounders between groups. The primary outcome was the live birth rate (LBR). Multivariable logistic analysis was used to evaluate the difference between these two protocols in relation to the LBR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result(s)<\/jats:title>\n                <jats:p>In this study, 1:1 propensity score matching was performed to create a perfect match of 964 patients in each group. After matching, the blastocyst formation rates, oestradiol (E<jats:sub>2<\/jats:sub>) value on Day hCG\u2009+\u20099, progesterone (P) value on Day hCG\u2009+\u20099, implantation rates, clinical pregnancy rates, and LBR were more favourable in the depot GnRH-a protocol than in the long GnRH-a protocol (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). However, the moderate or severe OHSS rates were higher in the depot group than in the long group (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). There were no significant differences in endometrial thickness, luteal support medication, early pregnancy loss rates, mid- and late-term pregnancy loss rates, or foetal malformation rates between the two protocols.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion(s)<\/jats:title>\n                <jats:p>Compared with the daily short-acting GnRH agonist protocol, the follicular-phase depot GnRH-a protocol might improve LBRs in normogonadotropic women without discernible differences in luteal function and child health.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-022-01014-0","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T08:03:12Z","timestamp":1663574592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The follicular-phase depot GnRH agonist protocol results in a higher live birth rate without discernible differences in luteal function and child health versus the daily mid-luteal GnRH agonist protocol: a single-centre, retrospective, propensity score matched cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglu","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changjun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,19]]},"reference":[{"key":"1014_CR1","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4103\/0974-1208.153124","volume":"8","author":"C Liao","year":"2015","unstructured":"Liao C, Huang R, Scherer RW, Liang XY. Prognostic factors associated with clinical pregnancy in in vitro fertilization using pituitary down-regulation with depot and daily low-dose luteal phase gonadotropin releasing hormone agonists: a single center\u2019s experience. J Hum Reprod Sci. 2015;8:30\u20136.","journal-title":"J Hum Reprod Sci"},{"key":"1014_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.5114\/aoms.2014.40743","volume":"10","author":"GH Mao","year":"2014","unstructured":"Mao GH, Feng Z, He Y, Huang YR. Comparisons of the effects of long-acting and short-acting GnRH agonists on embryo quality, endometrial thickness and pregnancy rate in human in vitro fertilization. Arch Med Sci. 2014;10:161\u20136.","journal-title":"Arch Med Sci"},{"key":"1014_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1177\/1933719118816835","volume":"26","author":"J Song","year":"2018","unstructured":"Song J, Sun X, Qian K. Endometrial but not ovarian response is associated with clinical outcomes and can be improved by prolonged pituitary downregulation in patients with thin and medium endometrium. Reprod Sci. 2018;26:1409\u201316.","journal-title":"Reprod Sci"},{"key":"1014_CR4","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1093\/oxfordjournals.humrep.a136090","volume":"10","author":"OA Oyesanya","year":"1995","unstructured":"Oyesanya OA, Teo SK, Quah E, Abdurazak N, Lee FY, Cheng WC. Pituitary down-regulation prior to in-vitro fertilization and embryo transfer: a comparison between a single dose of Zoladex depot and multiple daily doses of Suprefact. Hum Reprod. 1995;10:1042\u20134.","journal-title":"Hum Reprod"},{"key":"1014_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/09513599209015549","volume":"6","author":"FJ Broekmans","year":"1992","unstructured":"Broekmans FJ, Bernardus RE, Berkhout G, Schoemaker J. Pituitary and ovarian suppression after early follicular and mid-luteal administration of a LHRH agonist in a depot formulation: decapeptyl CR. Gynecol Endocrinol. 1992;6:153\u201361.","journal-title":"Gynecol Endocrinol"},{"key":"1014_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0015-0282(99)00608-1","volume":"73","author":"Y Hsieh","year":"2000","unstructured":"Hsieh Y, Tsai H, Chang C, Lo H. Comparison of a single half-dose, long-acting form of gonadotropin-releasing hormone analog (GnRH-a) and a short-acting form of GnRH-a for pituitary suppression in a controlled ovarian hyperstimulation program. Fertil Steril. 2000;73:817\u201320.","journal-title":"Fertil Steril"},{"key":"1014_CR7","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1093\/humrep\/deh415","volume":"19","author":"L Dal Prato","year":"2004","unstructured":"Dal Prato L, Borini A, Coticchio G, Cattoli M, Flamigni C. Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study. Hum Reprod. 2004;19:2200\u20135.","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"1014_CR8","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/j.ejogrb.2004.01.014","volume":"115","author":"L Dal Prato","year":"2004","unstructured":"Dal Prato L, Borini A, Cattoli M, Bonu MA, Sereni E, Flamigni C. GnRH analogs: depot versus short formulations. Eur J Obstet Gynecol Reprod Biol. 2004;115(Suppl 1):S40-43.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"1014_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.0001-6349.2004.00543.x","volume":"83","author":"K Zikopoulos","year":"2004","unstructured":"Zikopoulos K, Kolibianakis EM, Devroey P. Ovarian stimulation for in vitro fertilization in patients with endometriosis. Acta Obstet Gynecol Scand. 2004;83:651\u20135.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"1014_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.rbmo.2020.07.027","volume":"41","author":"X Hou","year":"2020","unstructured":"Hou X, Xing J, Shan H, Mei J, Sun Y, Yan G, Sun H, Wang J. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment. Reprod Biomed Online. 2020;41:845\u201353.","journal-title":"Reprod Biomed Online"},{"key":"1014_CR11","doi-asserted-by":"publisher","first-page":"609771","DOI":"10.3389\/fendo.2021.609771","volume":"12","author":"J Lan","year":"2021","unstructured":"Lan J, Wu Y, Wu Z, Wu Y, Yang R, Liu Y, Lin H, Jiao X, Zhang Q. Ultra-Long GnRH Agonist Protocol During IVF\/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study. Front Endocrinol (Lausanne). 2021;12:609771.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1014_CR12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.fertnstert.2014.03.030","volume":"102","author":"J Ren","year":"2014","unstructured":"Ren J, Sha A, Han D, Li P, Geng J, Ma C. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment? Fertil Steril. 2014;102:75\u201381.","journal-title":"Fertil Steril"},{"key":"1014_CR13","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1093\/humrep\/deaa086","volume":"35","author":"B Xu","year":"2020","unstructured":"Xu B, Geerts D, Hu S, Yue J, Li Z, Zhu G, Jin L. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study. Hum Reprod. 2020;35:1306\u201318.","journal-title":"Hum Reprod"},{"key":"1014_CR14","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/humrep\/14.2.288","volume":"14","author":"T Dada","year":"1999","unstructured":"Dada T, Salha O, Baillie HS, Sharma V. A comparison of three gonadotrophin-releasing hormone analogues in an in-vitro fertilization programme: a prospective randomized study. Hum Reprod. 1999;14:288\u201393.","journal-title":"Hum Reprod"},{"key":"1014_CR15","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1093\/humrep\/dem223","volume":"22","author":"L Safdarian","year":"2007","unstructured":"Safdarian L, Mohammadi FS, Alleyassin A, Aghahosseini M, Meysamie A, Rahimi E. Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI\/embryo transfer: a randomized double-blind clinical trial (NCT00461916). Hum Reprod. 2007;22:2449\u201354.","journal-title":"Hum Reprod"},{"key":"1014_CR16","doi-asserted-by":"publisher","first-page":"945","DOI":"10.5114\/aoms.2010.19306","volume":"6","author":"E Tehraninejad","year":"2010","unstructured":"Tehraninejad E, Nekoo EA, Ezabadi Z, Rashidi BH, Amirchaghmaghi E, Matroud EP. Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF\/ICSI cycles. Arch Med Sci. 2010;6:945\u20139.","journal-title":"Arch Med Sci"},{"key":"1014_CR17","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1177\/1933719118816835","volume":"26","author":"J Song","year":"2019","unstructured":"Song J, Sun X, Qian K. Endometrial but not ovarian response is associated with clinical outcomes and can be improved by prolonged pituitary downregulation in patients with thin and medium endometrium. Reprod Sci. 2019;26:1409\u201316.","journal-title":"Reprod Sci"},{"key":"1014_CR18","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3346\/jkms.2008.23.4.662","volume":"23","author":"KW Cheon","year":"2008","unstructured":"Cheon KW, Song SJ, Choi BC, Lee SC, Lee HB, Yu SY, Yoo KJ. Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles. J Korean Med Sci. 2008;23:662\u20136.","journal-title":"J Korean Med Sci"},{"key":"1014_CR19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1023\/A:1016054424966","volume":"19","author":"S Geber","year":"2002","unstructured":"Geber S, Sales L, Sampaio MA. Comparison between a single dose of goserelin (depot) and multiple daily doses of leuprolide acetate for pituitary suppression in IVF treatment: a clinical endocrinological study of the ovarian response. J Assist Reprod Genet. 2002;19:313\u20138.","journal-title":"J Assist Reprod Genet"},{"key":"1014_CR20","doi-asserted-by":"crossref","unstructured":"Kol S. Time, time, time: see what governs the luteal phase endocrinology. Gynecol Endocrinol. 2021;37:775\u201377.","DOI":"10.1080\/09513590.2021.1939297"},{"key":"1014_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0015-0282(16)55188-7","volume":"58","author":"D Navot","year":"1992","unstructured":"Navot D, Bergh PA, Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril. 1992;58:249\u201361.","journal-title":"Fertil Steril"},{"key":"1014_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0015-0282(16)56827-7","volume":"62","author":"E Porcu","year":"1994","unstructured":"Porcu E, Dal Prato L, Seracchioli R, Fabbri R, Longhi M, Flamigni C. Comparison between depot and standard release triptoreline in in vitro fertilization: pituitary sensitivity, luteal function, pregnancy outcome, and perinatal results. Fertil Steril. 1994;62:126\u201332.","journal-title":"Fertil Steril"},{"key":"1014_CR23","first-page":"53","volume":"36","author":"E Knobil","year":"1980","unstructured":"Knobil E. The neuroendocrine control of the menstrual cycle. Recent Prog Horm Res. 1980;36:53\u201388.","journal-title":"Recent Prog Horm Res"},{"key":"1014_CR24","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/S1297-9589(02)00461-7","volume":"30","author":"E Loumaye","year":"2002","unstructured":"Loumaye E. Ovarian stimulation: is exogenous LH necessary in all patients? Gynecol Obstet Fertil. 2002;30:890\u20135.","journal-title":"Gynecol Obstet Fertil"},{"key":"1014_CR25","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/03007995.2017.1417827","volume":"34","author":"JS Younis","year":"2018","unstructured":"Younis JS, Laufer N. Recombinant luteinizing hormone supplementation to recombinant follicle stimulating hormone therapy in gonadotropin releasing hormone analogue cycles: what is the evidence? Curr Med Res Opin. 2018;34:881\u20136.","journal-title":"Curr Med Res Opin"},{"key":"1014_CR26","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1185\/03007990802374815","volume":"24","author":"L O'Dea","year":"2008","unstructured":"O\u2019Dea L, O\u2019Brien F, Currie K, Hemsey G. Follicular development induced by recombinant luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in anovulatory women with LH and FSH deficiency: evidence of a threshold effect. Curr Med Res Opin. 2008;24:2785\u201393.","journal-title":"Curr Med Res Opin"},{"key":"1014_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s10815-005-5998-8","volume":"22","author":"B Sonntag","year":"2005","unstructured":"Sonntag B, Kiesel L, Nieschlag E, Behre HM. Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART. J Assist Reprod Genet. 2005;22:277\u201383.","journal-title":"J Assist Reprod Genet"},{"key":"1014_CR28","doi-asserted-by":"publisher","first-page":"2868","DOI":"10.1093\/humrep\/dep263","volume":"24","author":"D Haouzi","year":"2009","unstructured":"Haouzi D, Assou S, Mahmoud K, Hedon B, De Vos J, Dewailly D, Hamamah S. LH\/hCGR gene expression in human cumulus cells is linked to the expression of the extracellular matrix modifying gene TNFAIP6 and to serum estradiol levels on day of hCG administration. Hum Reprod. 2009;24:2868\u201378.","journal-title":"Hum Reprod"},{"key":"1014_CR29","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.2741\/2189","volume":"12","author":"M Fu","year":"2007","unstructured":"Fu M, Chen X, Yan J, Lei L, Jin S, Yang J, Song X, Zhang M, Xia G. Luteinizing hormone receptors expression in cumulus cells closely related to mouse oocyte meiotic maturation. Front Biosci. 2007;12:1804\u201313.","journal-title":"Front Biosci"},{"key":"1014_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.fertnstert.2011.06.015","volume":"96","author":"J Chai","year":"2011","unstructured":"Chai J, Lee KF, Ng EH, Yeung WS, Ho PC. Ovarian stimulation modulates steroid receptor expression and spheroid attachment in peri-implantation endometria: studies on natural and stimulated cycles. Fertil Steril. 2011;96:764\u20138.","journal-title":"Fertil Steril"},{"key":"1014_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/humrep\/dep429","volume":"25","author":"Y Liu","year":"2010","unstructured":"Liu Y, Kodithuwakku SP, Ng PY, Chai J, Ng EH, Yeung WS, Ho PC, Lee KF. Excessive ovarian stimulation up-regulates the Wnt-signaling molecule DKK1 in human endometrium and may affect implantation: an in vitro co-culture study. Hum Reprod. 2010;25:479\u201390.","journal-title":"Hum Reprod"},{"key":"1014_CR32","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11596-019-2056-9","volume":"39","author":"L Wu","year":"2019","unstructured":"Wu L, Ren XL, Chen W, Huang B, Zhou YF, Jin L. Influence of Different Gonadotropin-releasing hormone agonist administration methods on pregnancy outcomes of patients undergoing in-vitro fertilization-embryo transfer. Curr Med Sci. 2019;39:437\u201341.","journal-title":"Curr Med Sci"},{"key":"1014_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ando.2016.04.013","volume":"77","author":"O Sandra","year":"2016","unstructured":"Sandra O. Hormonal control of implantation. Ann Endocrinol (Paris). 2016;77:63\u20136.","journal-title":"Ann Endocrinol (Paris)"},{"key":"1014_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/humrep\/dez235","volume":"35","author":"LN Vuong","year":"2020","unstructured":"Vuong LN, Ho TM, Pham TD, Ho VNA, Andersen CY, Humaidan P. The early luteal hormonal profile in IVF patients triggered with hCG. Hum Reprod. 2020;35:157\u201366.","journal-title":"Hum Reprod"},{"key":"1014_CR35","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/humrep\/15.5.1003","volume":"15","author":"LG Westergaard","year":"2000","unstructured":"Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum Reprod. 2000;15:1003\u20138.","journal-title":"Hum Reprod"},{"key":"1014_CR36","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12958-021-00732-1","volume":"19","author":"H Wu","year":"2021","unstructured":"Wu H, Xu X, Ma C, Zhou Y, Pei S, Geng H, He Y, Xu Q, Xu Y, He X, et al. No significant long-term complications from inadvertent exposure to gonadotropin-releasing hormone agonist during early pregnancy in mothers and offspring: a retrospective analysis. Reprod Biol Endocrinol. 2021;19:46.","journal-title":"Reprod Biol Endocrinol"},{"key":"1014_CR37","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1093\/oxfordjournals.humrep.a138686","volume":"9","author":"DJ Cahill","year":"1994","unstructured":"Cahill DJ, Fountain SA, Fox R, Fleming CF, Brinsden PR, Hull MG. Outcome of inadvertent administration of a gonadotrophin-releasing hormone agonist (buserelin) in early pregnancy. Hum Reprod. 1994;9:1243\u20136.","journal-title":"Hum Reprod"},{"key":"1014_CR38","first-page":"e929854","volume":"27","author":"J Song","year":"2021","unstructured":"Song J, Wu W, Jiang L, Duan C, Xu J. Effects of different exposure days to Gonadotropin-Releasing Hormone Agonist (GnRH-a) on live birth rates in the depot GnRH-a Protocol: a retrospective analysis of 7007 cycles. Med Sci Monit. 2021;27:e929854.","journal-title":"Med Sci Monit"},{"key":"1014_CR39","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1111\/aogs.13691","volume":"98","author":"AS Kohl Schwartz","year":"2019","unstructured":"Kohl Schwartz AS, Mitter VR, Amylidi-Mohr S, Fasel P, Minger MA, Limoni C, Zwahlen M, von Wolff M. The greater incidence of small-for-gestational-age newborns after gonadotropin-stimulated in vitro fertilization with a supraphysiological estradiol level on ovulation trigger day. Acta Obstet Gynecol Scand. 2019;98:1575\u201384.","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-01014-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-022-01014-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-022-01014-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T13:33:42Z","timestamp":1664976822000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-022-01014-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,19]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1014"],"URL":"https:\/\/doi.org\/10.1186\/s12958-022-01014-0","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,19]]},"assertion":[{"value":"2 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the principles of the Declaration of Helsinki and was approved by the Ethics Committee of Renmin Hospital, Hubei Medical University. Anonymous data were collected from the Reproductive Medicine Center, Renmin Hospital, Hubei University of Medicine, between January 2016 and September 2020.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"140"}}